Literature DB >> 33535984

Subcortical and brainstem hemiatrophy accompanied by iron deposition in a patient with hemiparkinsonism-hemiatrophy syndrome: a case report.

Su Jin Chung1.   

Abstract

BACKGROUND: There is no established pathogenesis of hemiparkinsonism-hemiatrophy syndrome (HPHA), and the varied clinical presentations have been reported in several case studies. To the best of our knowledge, the present report describes the first case of HPHA with unusual brain imaging findings. CASE
PRESENTATION: A 20-year-old man presented with a 6-month history of weakness and clumsiness in his right limbs. He showed right-sided parkinsonism with dystonic hand posture; however, body asymmetry was not noted. Brain imaging revealed hemiatrophy of the left hemisphere subcortical structures and brainstem, and iron deposition in the left globus pallidus and substantia nigra. In addition, dopamine transporter imaging demonstrated normal presynaptic dopaminergic function. The patient was treated with levodopa, which had little to no effect.
CONCLUSIONS: This case demonstrates the unique imaging characteristics of HPHA associated with widespread brain hemiatrophy and iron deposition. Further studies are needed to elucidate the diagnostic criteria for this heterogeneous syndrome.

Entities:  

Keywords:  Brainstem; Hemiatrophy; Hemiparkinsonism; Iron; Subcortex

Mesh:

Substances:

Year:  2021        PMID: 33535984      PMCID: PMC7856800          DOI: 10.1186/s12883-021-02080-4

Source DB:  PubMed          Journal:  BMC Neurol        ISSN: 1471-2377            Impact factor:   2.474


  16 in total

1.  Hemiparkinsonism-hemiatrophy syndrome: clinical and neuroradiologic features.

Authors:  N Giladi; R E Burke; V Kostic; S Przedborski; M Gordon; A Hunt; S Fahn
Journal:  Neurology       Date:  1990-11       Impact factor: 9.910

Review 2.  The history of iron in the brain.

Authors:  A H Koeppen
Journal:  J Neurol Sci       Date:  1995-12       Impact factor: 3.181

Review 3.  The role of iron in brain ageing and neurodegenerative disorders.

Authors:  Roberta J Ward; Fabio A Zucca; Jeff H Duyn; Robert R Crichton; Luigi Zecca
Journal:  Lancet Neurol       Date:  2014-10       Impact factor: 44.182

Review 4.  Identification of mineral deposits in the brain on radiological images: a systematic review.

Authors:  Maria del C Valdés Hernández; Lucy C Maconick; Elizabeth M J Tan; Joanna M Wardlaw
Journal:  Eur Radiol       Date:  2012-06-12       Impact factor: 5.315

Review 5.  Iron metabolism in the CNS: implications for neurodegenerative diseases.

Authors:  Tracey A Rouault
Journal:  Nat Rev Neurosci       Date:  2013-07-03       Impact factor: 34.870

6.  T2* and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation.

Authors:  A McNeill; D Birchall; S J Hayflick; A Gregory; J F Schenk; E A Zimmerman; H Shang; H Miyajima; P F Chinnery
Journal:  Neurology       Date:  2008-04-29       Impact factor: 9.910

7.  Degeneration of nigrostriatal dopaminergic neurons increases iron within the substantia nigra: a histochemical and neurochemical study.

Authors:  E Oestreicher; G J Sengstock; P Riederer; C W Olanow; A J Dunn; G W Arendash
Journal:  Brain Res       Date:  1994-10-10       Impact factor: 3.252

8.  Region-specific disturbed iron distribution in early idiopathic Parkinson's disease measured by quantitative susceptibility mapping.

Authors:  Naying He; Huawei Ling; Bei Ding; Juan Huang; Yong Zhang; Zhongping Zhang; Chunlei Liu; Kemin Chen; Fuhua Yan
Journal:  Hum Brain Mapp       Date:  2015-08-07       Impact factor: 5.038

9.  Hemiparkinsonism-hemiatrophy syndrome.

Authors:  Subhashie Wijemanne; Joseph Jankovic
Journal:  Neurology       Date:  2007-10-16       Impact factor: 9.910

10.  Impairment of Motor Function Correlates with Neurometabolite and Brain Iron Alterations in Parkinson's Disease.

Authors:  Beate Pesch; Swaantje Casjens; Dirk Woitalla; Shalmali Dharmadhikari; David A Edmondson; Maria Angela Samis Zella; Martin Lehnert; Anne Lotz; Lennard Herrmann; Siegfried Muhlack; Peter Kraus; Chien-Lin Yeh; Benjamin Glaubitz; Tobias Schmidt-Wilcke; Ralf Gold; Christoph van Thriel; Thomas Brüning; Lars Tönges; Ulrike Dydak
Journal:  Cells       Date:  2019-01-29       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.